MedTrace Logo

Gram Negative Bacteremia, Risk Factors for Failure of Therapy

NCT00177957 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 600

Last updated 2017-06-09

No results posted yet for this study

Summary

The aims of this study are to:

* Determine the risk factors for multidrug resistance in bloodstream isolates of Gram negative bacilli
* Determine the mechanisms of multidrug resistance in bloodstream isolates of Gram negative bacilli
* Determine the risk factors for failure of prompt clearance of the blood of Gram negative bacteria
* Determine the survival of patients with Gram negative bacteremia
* Determine if failure of prompt clearance of the blood of Gram negative bacteria is a predictor of mortality following this infection

Conditions

  • Gram-Negative Bacterial Infections

Sponsors & Collaborators

  • PI discretionary funding

    collaborator UNKNOWN

  • University of Pittsburgh

    lead OTHER

Principal Investigators

  • Yohei Doi, MD · University of Pittsburgh

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-04-30
Primary Completion
2016-05-31
Completion
2016-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00177957 on ClinicalTrials.gov